Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 8

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 4
Chunk 8
---
ITEM
4. INFORMATION ON THE COMPANY

4. A.
History and Development of the Company

Capital
Pool Company

The
Company was incorporated by registration of its Memorandum and Articles under the BC Companies Act on May 30, 2000 under the name “ Duft
Biotech Capital Ltd.” and was classified as a Capital Pool Company (“ CPC”) on the TSX Venture Exchange. Under the policies
of the TSX Venture Exchange, the principal business of a CPC is to identify and evaluate opportunities for acquisition. The completion
of such an acquisition is referred to as a Qualifying Transaction. A CPC does not carry on any business other than the identification
and evaluation of assets or businesses in connection with potential Qualifying Transactions, does not have business operations or assets
other than seed capital and has no written or oral agreements for the acquisition of an asset or business at the time of formation.

A
“ Qualifying Transaction”, pursuant to the policies of the TSX Venture Exchange, is a transaction whereby a capital pool company:

  (a)      Issues                                                                                            
  (b)      Enters                                                                                            
  (c)      Otherwise                                                                                         

On
November 13, 2003, the Company acquired the assets of ALDA Pharmaceuticals Inc. (“ API”), a private company founded in 1996.

Financings

The
Company has financed its operations since inception through funds raised in a series of private placements of common shares:

  Fiscal Year Ended                  Nature of Share Issuance                                                                        Amount ($)  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  30-Jun-2001                        Private Placement @                                                  $0.34         294,119        $100,000  
  30-Jun-2002                        Canadian Prospectus Offering (IPO) @                                 $0.68         300,000        $204,000  
  30-Jun-2003                        Broker’s Warrant Shares on Canadian Prospectus Offering (IPO) @      $0.68          37,500         $25,500  
  30-Jun-2004                        Private Placement @                                                  $0.60          86,667         $52,000  
                                     Private Placement @                                                  $0.80       1,550,000      $1,240,000  
  30-Jun-2005                        Private Placement @                                                  $0.40         750,000        $300,000  
  30-Jun